A citation-based method for searching scientific literature

Effects of zonisamide on K+ and Ca2+ evoked release of monoamine as well as K+ evoked intracellular Ca2+ mobilization in rat hippocampus.
Y Kawata, M Okada, T Murakami, K Mizuno, K Wada, T Kondo, S Kaneko. Epilepsy Res 1999
Times Cited: 30






Login to export Results
Don't have an account? Register here

List of co-cited articles
329 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of zonisamide on dopaminergic system.
M Okada, S Kaneko, T Hirano, K Mizuno, T Kondo, K Otani, Y Fukushima. Epilepsy Res 1995
154
18
60

Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode.
M Okada, Y Kawata, K Mizuno, K Wada, T Kondo, S Kaneko. Br J Pharmacol 1998
100
14
46

Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex.
S Suzuki, K Kawakami, S Nishimura, Y Watanabe, K Yagi, M Seino, K Miyamoto. Epilepsy Res 1992
231
12
40

Biphasic effects of zonisamide on serotonergic system in rat hippocampus.
M Okada, T Hirano, Y Kawata, T Murakami, K Wada, K Mizuno, T Kondo, S Kaneko. Epilepsy Res 1999
79
12
40

Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant.
D M Rock, R L Macdonald, C P Taylor. Epilepsy Res 1989
105
9
30

Exocytosis mechanism as a new targeting site for mechanisms of action of antiepileptic drugs.
Motohiro Okada, Gan Zhu, Shukuko Yoshida, Kazuaki Kanai, Shinichi Hirose, Sunao Kaneko. Life Sci 2002
34
9
30

Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
S Yamamura, K Ohoyama, H Nagase, M Okada. Neuropharmacology 2009
47
8
26

ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation.
Satoshi Yamamura, Masamitsu Hoshikawa, Kato Dai, Hiromitsu Saito, Noboru Suzuki, Osamu Niwa, Motohiro Okada. Br J Pharmacol 2013
48
8
26

Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor.
Kouji Fukuyama, Masashi Fukuzawa, Takashi Shiroyama, Motohiro Okada. Br J Pharmacol 2020
27
8
29

Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway.
Kouji Fukuyama, Shunske Tanahashi, Masamitsu Hoshikawa, Rika Shinagawa, Motohiro Okada. Neuropharmacology 2014
34
8
26

Are some idiopathic epilepsies disorders of ion channels?: A working hypothesis.
S Hirose, M Okada, S Kaneko, A Mitsudome. Epilepsy Res 2000
61
7
23

Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder.
I E Scheffer, K P Bhatia, I Lopes-Cendes, D R Fish, C D Marsden, F Andermann, E Andermann, R Desbiens, F Cendes, J I Manson. Lancet 1994
260
7
23

Interaction between carbamazepine, zonisamide and voltage-sensitive Ca2+ channel on acetylcholine release in rat frontal cortex.
Gang Zhu, Motohiro Okada, Takuya Murakami, Yuko Kawata, Akihisa Kamata, Sunao Kaneko. Epilepsy Res 2002
31
7
23

Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors.
Shukuko Yoshida, Motohiro Okada, Gang Zhu, Sunao Kaneko. Epilepsy Res 2005
39
7
23

Carbamazepine Attenuates Astroglial L-Glutamate Release Induced by Pro-Inflammatory Cytokines via Chronically Activation of Adenosine A2A Receptor.
Motohiro Okada, Kouji Fukuyama, Takashi Shiroyama, Yuto Ueda. Int J Mol Sci 2019
20
7
35

Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites.
Kouji Fukuyama, Motohiro Okada. Br J Pharmacol 2018
20
7
35

Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis.
M Okada, K Kiryu, Y Kawata, K Mizuno, K Wada, H Tasaki, S Kaneko. Eur J Pharmacol 1997
105
6
20

Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca(2+)- and K(+)-evoked serotonin release.
Y Kawata, M Okada, T Murakami, A Kamata, G Zhu, S Kaneko. Br J Pharmacol 2001
42
6
20

Effects of carbamazepine on hippocampal serotonergic system.
M Okada, T Hirano, K Mizuno, Y Kawata, K Wada, T Murakami, H Tasaki, S Kaneko. Epilepsy Res 1998
47
6
20

Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus.
M Okada, T Hirano, K Mizuno, T Chiba, Y Kawata, K Kiryu, K Wada, H Tasaki, S Kaneko. Epilepsy Res 1997
48
6
20

Mechanisms of T-type calcium channel blockade by zonisamide.
M Kito, M Maehara, K Watanabe. Seizure 1996
114
6
20

Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release.
M Okada, S Kaneko, T Hirano, M Ishida, T Kondo, K Otani, Y Fukushima. Epilepsy Res 1992
76
6
20

Electroclinical picture of autosomal dominant nocturnal frontal lobe epilepsy in a Japanese family.
M Ito, K Kobayashi, T Fujii, T Okuno, S Hirose, H Iwata, A Mitsudome, S Kaneko. Epilepsia 2000
57
6
20

Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals.
Y Masuda, Y Utsui, Y Shiraishi, T Karasawa, K Yoshida, M Shimizu. Epilepsia 1979
116
6
20

Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis.
T Murakami, M Okada, Y Kawata, G Zhu, A Kamata, S Kaneko. Br J Pharmacol 2001
44
6
20

Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
Miho Murata, Kazuko Hasegawa, Ichiro Kanazawa. Neurology 2007
173
6
20

Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin.
Satoshi Yamamura, Tatsuya Hamaguchi, Keiko Ohoyama, Yoshihiro Sugiura, Dai Suzuki, Shinich Kanehara, Masanori Nakagawa, Eishi Motomura, Takuya Matsumoto, Hisashi Tanii,[...]. Epilepsy Res 2009
29
6
20

Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex.
Motohiro Okada, Kouji Fukuyama, Yasuhiro Kawano, Takashi Shiroyama, Dai Suzuki, Yuto Ueda. Neuropharmacology 2019
27
6
22

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
Simon D Harding, Joanna L Sharman, Elena Faccenda, Chris Southan, Adam J Pawson, Sam Ireland, Alasdair J G Gray, Liam Bruce, Stephen P H Alexander, Stephen Anderton,[...]. Nucleic Acids Res 2018
1400
6
20

Autism in siblings with autosomal dominant nocturnal frontal lobe epilepsy.
Tomoko Miyajima, Tomohiro Kumada, Keiko Saito, Tatsuya Fujii. Brain Dev 2013
9
6
66

Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc<sup/>.
Motohiro Okada, Kouji Fukuyama, Yasuhiro Kawano, Takashi Shiroyama, Yuto Ueda. Pharmacol Res Perspect 2019
39
6
20

Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT7 receptor blockade.
Motohiro Okada, Kouji Fukuyama, Yuto Ueda. Br J Pharmacol 2019
26
6
23

Role of connexin 43 in different forms of intercellular communication - gap junctions, extracellular vesicles and tunnelling nanotubes.
Teresa M Ribeiro-Rodrigues, Tânia Martins-Marques, Sandrine Morel, Brenda R Kwak, Henrique Girão. J Cell Sci 2017
104
6
20

Upregulated and Hyperactivated Thalamic Connexin 43 Plays Important Roles in Pathomechanisms of Cognitive Impairment and Seizure of Autosomal Dominant Sleep-Related Hypermotor Epilepsy with S284L-Mutant α4 Subunit of Nicotinic ACh Receptor.
Kouji Fukuyama, Masashi Fukuzawa, Motohiro Okada. Pharmaceuticals (Basel) 2020
19
6
31

Upregulated Connexin 43 Induced by Loss-of-Functional S284L-Mutant α4 Subunit of Nicotinic ACh Receptor Contributes to Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy.
Kouji Fukuyama, Masashi Fukuzawa, Ruri Okubo, Motohiro Okada. Pharmaceuticals (Basel) 2020
20
6
30

Effects of Ca2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis.
M Okada, K Wada, K Kiryu, Y Kawata, K Mizuno, T Kondo, H Tasaki, S Kaneko. Br J Pharmacol 1998
36
5
16

Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.
M J McLean, R L Macdonald. J Pharmacol Exp Ther 1986
233
5
16

Zonisamide enhances slow sodium inactivation in Myxicola.
C L Schauf. Brain Res 1987
139
5
16

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.
S Kanba, G Yagi, K Kamijima, T Suzuki, O Tajima, J Otaki, E Arata, H Koshikawa, M Nibuya, N Kinoshita. Prog Neuropsychopharmacol Biol Psychiatry 1994
78
5
16

Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release.
M Okada, D J Nutt, T Murakami, G Zhu, A Kamata, Y Kawata, S Kaneko. J Neurosci 2001
97
5
16

Zonisamide has beneficial effects on Parkinson's disease patients.
M Murata, E Horiuchi, I Kanazawa. Neurosci Res 2001
107
5
16

Effects of zonisamide on neurotransmitter release associated with inositol triphosphate receptors.
Satoshi Yamamura, Hiromitsu Saito, Noboru Suzuki, Sanae Kashimoto, Tatsuya Hamaguchi, Keiko Ohoyama, Dai Suzuki, Shinich Kanehara, Masanori Nakagawa, Takashi Shiroyama,[...]. Neurosci Lett 2009
19
5
26

Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex.
S Yamamura, K Ohoyama, T Hamaguchi, M Nakagawa, D Suzuki, T Matsumoto, E Motomura, H Tanii, T Shiroyama, M Okada. Br J Pharmacol 2009
48
5
16

Definition and diagnostic criteria of sleep-related hypermotor epilepsy.
Paolo Tinuper, Francesca Bisulli, J H Cross, Dale Hesdorffer, Philippe Kahane, Lino Nobili, Federica Provini, Ingrid E Scheffer, Laura Tassi, Luca Vignatelli,[...]. Neurology 2016
140
5
16

Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype.
Gang Zhu, Motohiro Okada, Shukuko Yoshida, Shinya Ueno, Fumiaki Mori, Tomoko Takahara, Ryo Saito, Yoshiki Miura, Akihiro Kishi, Masahiko Tomiyama,[...]. J Neurosci 2008
43
5
16

Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases.
F Provini, G Plazzi, P Tinuper, S Vandi, E Lugaresi, P Montagna. Brain 1999
308
5
16

Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor.
Kouji Fukuyama, Ryo Kato, Masahiko Murata, Takashi Shiroyama, Motohiro Okada. Biomolecules 2019
41
5
16

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors.
Stephen P H Alexander, Arthur Christopoulos, Anthony P Davenport, Eamonn Kelly, Alistair Mathie, John A Peters, Emma L Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding,[...]. Br J Pharmacol 2019
519
5
16

Amantadine Combines Astroglial System Xc- Activation with Glutamate/NMDA Receptor Inhibition.
Tomosuke Nakano, Toshiki Hasegawa, Dai Suzuki, Eishi Motomura, Motohiro Okada. Biomolecules 2019
29
5
17

Activation of Astroglial Connexin is Involved in Concentration-Dependent Double-Edged Sword Clinical Action of Clozapine.
Kouji Fukuyama, Ruri Okubo, Masahiko Murata, Takashi Shiroyama, Motohiro Okada. Cells 2020
20
5
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy